Gene · 657
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer. | MAbs | 2023 | 38084840 | PubTator, text mining | PubMed |
| Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition? | Int J Mol Sci | 2023 | 38069345 | PubTator, text mining | PubMed |
| SMAD4 variants and its genotype-phenotype correlations to juvenile polyposis syndrome. | Hered Cancer Clin Pract | 2023 | 38066625 | PubTator, text mining | PubMed |
| FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy. | Cell Rep Med | 2023 | 38052214 | PubTator, text mining | PubMed |
| BMP signaling in cancer stemness and differentiation. | Cell Regen | 2023 | 38049682 | PubTator, text mining | PubMed |
| ConDoR: tumor phylogeny inference with a copy-number constrained mutation loss model. | Genome Biol | 2023 | 38037115 | PubTator, text mining | PubMed |
| Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach. | Cell Commun Signal | 2023 | 38031192 | PubTator, text mining | PubMed |
| Research progress on the biological basis of Traditional Chinese Medicine syndromes of gastrointestinal cancers. | Heliyon | 2023 | 38027682 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer. | Genes (Basel) | 2023 | 38002942 | PubTator, text mining | PubMed |
| [Research Progress of Nrf2 and Ferroptosis in Tumor Drug Resistance]. | Zhongguo Fei Ai Za Zhi | 2023 | 37989339 | PubTator, text mining | PubMed |
| LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate. | Sci Rep | 2023 | 37985890 | PubTator, text mining | PubMed |
| Genetic insights: High germline variant rate in an indigenous African cohort with early-onset colorectal cancer. | Front Oncol | 2023 | 37965459 | PubTator, text mining | PubMed |
| CHEX-seq detects single-cell genomic single-stranded DNA with catalytical potential. | Nat Commun | 2023 | 37963886 | PubTator, text mining | PubMed |
| Endometrial Cancer Diagnosed at an Early Stage during Lynch Syndrome Surveillance: A Case Report. | Case Rep Oncol | 2023 | 37933313 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Early-onset Colorectal Cancer: A Review. | J Anus Rectum Colon | 2023 | 37900694 | PubTator, text mining | PubMed |
| Clinical Guidelines for Diagnosis and Management of Cowden Syndrome/PTEN Hamartoma Tumor Syndrome in Children and Adults-Secondary Publication. | J Anus Rectum Colon | 2023 | 37900693 | PubTator, text mining | PubMed |
| Polyposis found on index colonoscopy in a 56-year-old female - BMPR1A variant in juvenile polyposis syndrome: A case report. | World J Gastrointest Endosc | 2023 | 37900118 | PubTator, text mining | PubMed |
| A New Frameshift Mutation of PTEN Gene Associated with Cowden Syndrome-Case Report and Brief Review of the Literature. | Genes (Basel) | 2023 | 37895258 | PubTator, text mining | PubMed |
| BMP-9 Improves the Osteogenic Differentiation Ability over BMP-2 through p53 Signaling In Vitro in Human Periosteum-Derived Cells. | Int J Mol Sci | 2023 | 37894931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/657/papers?page=8